{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:18:12Z","timestamp":1778923092800,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["324392634 \\u2013 TRR 221"],"award-info":[{"award-number":["324392634 \\u2013 TRR 221"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["A06"],"award-info":[{"award-number":["A06"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jtct.2025.04.022","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T19:29:16Z","timestamp":1746559756000},"page":"584.e1-584.e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Selective H2-O Tissue Expression Reduces Risk for Graft-versus-Host Disease in an In Vivo Transplantation Model"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0189-0561","authenticated-orcid":false,"given":"J.","family":"Zeun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Neubeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Korn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Nagel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2990-3282","authenticated-orcid":false,"given":"T.","family":"Kunert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Brey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2708-9688","authenticated-orcid":false,"given":"I.","family":"Atreya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0554-4547","authenticated-orcid":false,"given":"L.","family":"Denzin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"B\u00e4uerle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hildner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"B\u00fcttner-Herold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mackensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Reimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.N.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.jtct.2025.04.022_bib0001","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease - biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jtct.2025.04.022_bib0002","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1182\/blood.2021012431","article-title":"Nonclassical manifestations of acute GVHD","volume":"138","author":"Zeiser","year":"2021","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.04.022_bib0003","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1084\/jem.190.5.617","article-title":"Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo","volume":"190","author":"Nishimura","year":"1999","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.jtct.2025.04.022_bib0004","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1084\/jem.20092450","article-title":"Bystander killing of cancer requires the cooperation of CD4(+) and CD8(+) T cells during the effector phase","volume":"207","author":"Schietinger","year":"2010","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.jtct.2025.04.022_bib0005","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1053\/bbmt.2002.v8.abbmt080625","article-title":"Randomized trial of CD8+ T-cell depletion in the prevention of graft-versus-host disease associated with donor lymphocyte infusion","volume":"8","author":"Soiffer","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2025.04.022_bib0006","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.3389\/fimmu.2018.03016","article-title":"CD4 donor lymphocyte infusion can cause conversion of chimerism without GVHD by inducing immune responses targeting minor histocompatibility antigens in HLA Class II","volume":"9","author":"van Balen","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jtct.2025.04.022_bib0007","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2006-03-005769","article-title":"Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reduced-intensity transplantation","volume":"109","author":"Meyer","year":"2007","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.jtct.2025.04.022_bib0008","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1182\/blood-2012-12-470872","article-title":"HLA class II upregulation during viral infection leads to HLA-DP-directed graft-versus-host disease after CD4+ donor lymphocyte infusion","volume":"122","author":"Stevanovic","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2025.04.022_bib0009","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V90.8.3204","article-title":"Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines","volume":"90","author":"Hill","year":"1997","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.jtct.2025.04.022_bib0010","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2011-12-399311","article-title":"Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO","volume":"120","author":"Kremer","year":"2012","journal-title":"Blood"},{"issue":"5335","key":"10.1016\/j.jtct.2025.04.022_bib0011","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1126\/science.278.5335.106","article-title":"Negative regulation by HLA-DO of MHC class II-restricted antigen processing","volume":"278","author":"Denzin","year":"1997","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.jtct.2025.04.022_bib0012","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s002510000210","article-title":"H2-M, a facilitator of MHC class II peptide loading, and its negative modulator H2-O are differentially expressed in response to proinflammatory cytokines","volume":"51","author":"Walter","year":"2000","journal-title":"Immunogenetics"},{"issue":"5","key":"10.1016\/j.jtct.2025.04.022_bib0013","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbmt.2014.02.005","article-title":"Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies","volume":"20","author":"Kremer","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.jtct.2025.04.022_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002401","article-title":"Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens","volume":"9","author":"Bernhardt","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"2","key":"10.1016\/j.jtct.2025.04.022_bib0015","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.immuni.2017.07.013","article-title":"Neutralizing antibody responses to viral infections are linked to the non-classical MHC Class II gene H2-Ob","volume":"47","author":"Denzin","year":"2017","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jtct.2025.04.022_bib0016","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"10.1016\/j.jtct.2025.04.022_bib0017","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.jtct.2025.04.022_bib0018","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1038\/nprot.2006.446","article-title":"High resolution colonoscopy in live mice","volume":"1","author":"Becker","year":"2006","journal-title":"Nat Protoc"},{"issue":"7","key":"10.1016\/j.jtct.2025.04.022_bib0019","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1136\/gutjnl-2014-308227","article-title":"Batf-dependent Th17 cells critically regulate IL-23 driven colitis-associated colon cancer","volume":"65","author":"Punkenburg","year":"2016","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.jtct.2025.04.022_bib0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1074\/mcp.RA118.000956","article-title":"HLA-DO modulates the diversity of the MHC-II self-peptidome","volume":"18","author":"Nanaware","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"10","key":"10.1016\/j.jtct.2025.04.022_bib0021","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood.V91.10.3671","article-title":"Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant","volume":"91","author":"Alyea","year":"1998","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.jtct.2025.04.022_bib0022","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.3390\/cancers12071974","article-title":"Reconstitution of T cell subsets following allogeneic hematopoietic cell transplantation","volume":"12","author":"Dekker","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.jtct.2025.04.022_bib0023","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1073\/pnas.0712250105","article-title":"Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity","volume":"105","author":"Griffioen","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"17","key":"10.1016\/j.jtct.2025.04.022_bib0024","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1182\/blood-2009-03-208017","article-title":"Identification of 4 new HLA-DR-restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity","volume":"114","author":"Stumpf","year":"2009","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.jtct.2025.04.022_bib0025","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1172\/JCI40220","article-title":"Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence","volume":"120","author":"Yi","year":"2010","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jtct.2025.04.022_bib0026","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.2020008464","article-title":"Permissive HLA-DPB1 mismatches in HCT depend on immunopeptidome divergence and editing by HLA-DM","volume":"137","author":"Meurer","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jtct.2025.04.022_bib0027","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1084\/jem.20012066","article-title":"Regulated expression of human histocompatibility leukocyte antigen (HLA)-DO during antigen-dependent and antigen-independent phases of B cell development","volume":"195","author":"Chen","year":"2002","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jtct.2025.04.022_bib0028","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/intimm\/9.3.355","article-title":"HLA-DO is an intracellular class II molecule with distinctive thymic expression","volume":"9","author":"Douek","year":"1997","journal-title":"Int Immunol"},{"issue":"6","key":"10.1016\/j.jtct.2025.04.022_bib0029","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.4049\/jimmunol.176.6.3536","article-title":"Human dendritic cell expression of HLA-DO is subset specific and regulated by maturation","volume":"176","author":"Hornell","year":"2006","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.jtct.2025.04.022_bib0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1084\/jem.176.2.495","article-title":"Two subsets of epithelial cells in the thymic medulla","volume":"176","author":"Surh","year":"1992","journal-title":"J Exp Med"},{"issue":"6326","key":"10.1016\/j.jtct.2025.04.022_bib0031","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/351485a0","article-title":"A novel class II MHC molecule with unusual tissue distribution","volume":"351","author":"Karlsson","year":"1991","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jtct.2025.04.022_bib0032","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.4049\/jimmunol.178.3.1488","article-title":"Expression patterns of H2-O in mouse B cells and dendritic cells correlate with cell function","volume":"178","author":"Fallas","year":"2007","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.jtct.2025.04.022_bib0033","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1182\/blood.V76.8.1464.1464","article-title":"A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment","volume":"76","author":"Martin","year":"1990","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jtct.2025.04.022_bib0034","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.immuni.2019.08.011","article-title":"MHC Class II antigen presentation by the intestinal epithelium initiates graft-versus-host disease and is influenced by the microbiota","volume":"51","author":"Koyama","year":"2019","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jtct.2025.04.022_bib0035","first-page":"340","article-title":"The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia","volume":"91","author":"Sanchez-Garcia","year":"2006","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.jtct.2025.04.022_bib0036","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1182\/blood-2005-02-0509","article-title":"In vivo analyses of early events in acute graft-versus-host disease reveal sequential infiltration of T-cell subsets","volume":"106","author":"Beilhack","year":"2005","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725011625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636725011625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:00:28Z","timestamp":1778922028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636725011625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2666636725011625"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2025.04.022","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective H2-O Tissue Expression Reduces Risk for Graft-versus-Host Disease in an In Vivo Transplantation Model","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2025.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}